| Health Catalyst, Inc. (HCAT) Q1 2025 Earnings Call Transcript |
Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Richard Close - Canaccord Genuity Daniel Grosslight - Citi Jenny Shen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Sarah James - Cantor Operator Welcome to the Health Catalyst First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. |
seekingalpha.com |
2025-05-08 11:33:27 |
Czytaj oryginał (ang.) |
| Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates |
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-05-07 22:30:40 |
Czytaj oryginał (ang.) |
| Health Catalyst (HCAT) Q1 Earnings Meet Estimates |
Health Catalyst (HCAT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago. |
zacks.com |
2025-05-07 22:15:35 |
Czytaj oryginał (ang.) |
| Health Catalyst Reports First Quarter 2025 Results |
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. “For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric,” said Dan Burton, CEO of Health Catalyst. |
globenewswire.com |
2025-05-07 20:03:00 |
Czytaj oryginał (ang.) |
| Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations |
Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY , April 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a strategic partnership with Microsoft to help healthcare organizations accelerate operational, clinical, and financial performance through AI-driven innovation. The collaboration further builds on Health Catalyst's expertise with Microsoft Azure and Azure AI Foundry capabilities, equipping healthcare organizations with advanced AI solutions to accelerate time to value, enhance care delivery, and drive measurable, long-term improvement. |
prnewswire.com |
2025-04-29 12:30:00 |
Czytaj oryginał (ang.) |
| Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 |
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. |
globenewswire.com |
2025-04-17 12:00:00 |
Czytaj oryginał (ang.) |
| Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 |
AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players. |
zacks.com |
2025-04-10 20:00:34 |
Czytaj oryginał (ang.) |
| Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™ |
SALT LAKE CITY , April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite Spark™, a tailored data and analytics solution built for community health systems, regional hospitals, and multi-site practices. Smaller community health systems across the U.S. are navigating shrinking margins, policy uncertainty, and rising pressure to deliver more with less. |
prnewswire.com |
2025-04-10 12:30:00 |
Czytaj oryginał (ang.) |
| Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook |
Despite a 50% drop in HCAT's stock price, the company shows significant growth, reporting $307M in revenue and $26M in adjusted EBITDA for 2024. Health Catalyst focuses on efficiency, exiting lower-margin segments, and pushing AI-driven efficiencies, aiming for improved margins and profitability in 2025. The company forecasts strong growth with 40 new platform clients in 2025 and expects $335M in revenue, trading at a significant discount compared to industry peers. |
seekingalpha.com |
2025-03-25 17:53:55 |
Czytaj oryginał (ang.) |
| Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock? |
Investors need to pay close attention to Health Catalyst (HCAT) stock based on the movements in the options market lately. |
zacks.com |
2025-03-25 13:55:30 |
Czytaj oryginał (ang.) |
| Health Catalyst Announces ~$5 Million Stock Repurchase |
SALT LAKE CITY , March 11, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("Common Stock") in an aggregate amount of approximately $5 million. These repurchased shares were acquired between March 3, 2025, and March 10, 2025, as part of Health Catalyst's existing share repurchase program approved by its board of directors on August 2, 2022, which authorized repurchases of up to $40 million of Common Stock. |
prnewswire.com |
2025-03-11 10:30:00 |
Czytaj oryginał (ang.) |
| Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™ |
SALT LAKE CITY , Feb. 27, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system serving Southeastern Massachusetts. Signature Healthcare is collaborating with Health Catalyst to integrate data resource queries and unlock referral-related data powered by Health Catalyst Ignite™, a modern data and analytics ecosystem. |
prnewswire.com |
2025-02-27 18:05:00 |
Czytaj oryginał (ang.) |
| Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript |
Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Sameer Patel - Evercore ISI John Pinney - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst's Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. |
seekingalpha.com |
2025-02-27 01:23:03 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics |
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-26 22:00:31 |
Czytaj oryginał (ang.) |
| Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates |
Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.02 per share a year ago. |
zacks.com |
2025-02-26 21:10:19 |
Czytaj oryginał (ang.) |
| Health Catalyst Reports Fourth Quarter and Year End 2024 Results |
SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. |
globenewswire.com |
2025-02-26 18:03:00 |
Czytaj oryginał (ang.) |
| Health Catalyst to Participate in Upcoming Investor Conference |
SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Raymond James & Associates' 46th Annual Institutional Investors Conference, in Orlando, FL. Health Catalyst will host a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m. |
globenewswire.com |
2025-02-18 10:00:00 |
Czytaj oryginał (ang.) |
| Health Catalyst to Participate in Upcoming Investor Conference |
SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, and Dan LeSueur, Chief Operating Officer, will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, in Snowbird, UT, on Tuesday, February 11, 2025. |
globenewswire.com |
2025-01-30 10:00:00 |
Czytaj oryginał (ang.) |
| Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound |
The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are redefining how healthcare providers manage data, deliver care, and enhance patient outcomes. |
marketbeat.com |
2025-01-27 09:30:08 |
Czytaj oryginał (ang.) |
| OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care |
SALT LAKE CITY , Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with OrthoNebraska, a leading provider of orthopedic care headquartered in Omaha, Nebraska. Through this partnership, OrthoNebraska will leverage Health Catalyst Ignite™, a data and analytics ecosystem supported by best-in-class cross-industry technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern, scalable environment. |
prnewswire.com |
2025-01-13 10:00:00 |
Czytaj oryginał (ang.) |